G. Guzelant Et Al. , "EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME," 18th International Vasculitis and ANCA Workshop , vol.56, Tokyo, Japan, pp.94, 2017
Guzelant, G. Et Al. 2017. EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME. 18th International Vasculitis and ANCA Workshop , (Tokyo, Japan), 94.
Guzelant, G., Guzelant, G., Ucar, D., Hatemi, G., Ozyazgan, Y., Esatoglu, S. N., ... Yurdakul, S.(2017). EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME . 18th International Vasculitis and ANCA Workshop (pp.94). Tokyo, Japan
Guzelant, Gul Et Al. "EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME," 18th International Vasculitis and ANCA Workshop, Tokyo, Japan, 2017
Guzelant, Gul Et Al. "EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME." 18th International Vasculitis and ANCA Workshop , Tokyo, Japan, pp.94, 2017
Guzelant, G. Et Al. (2017) . "EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME." 18th International Vasculitis and ANCA Workshop , Tokyo, Japan, p.94.
@conferencepaper{conferencepaper, author={Gul Guzelant Et Al. }, title={EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME}, congress name={18th International Vasculitis and ANCA Workshop}, city={Tokyo}, country={Japan}, year={2017}, pages={94} }